Autolus Therapeutics plc (AUTL) Financials

AUTL Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 493.2 million 418.4 million
March 31, 2026 527.1 million 418.2 million
Dec. 31, 2025 589.1 million 410.9 million
Sept. 30, 2025 661.9 million 396.5 million

AUTL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -26.0 million 4.6 million
March 31, 2026 -68.0 million 3.6 million
Dec. 31, 2025 -91.1 million 3.4 million
Sept. 30, 2025 -52.4 million 3.8 million

AUTL Net Income

No data available :(

AUTL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 201.6 million - 83.5 million
March 31, 2026 229.4 million 76.9 million 3.1 million
Dec. 31, 2025 300.7 million 270.2 million 66.8 million
Sept. 30, 2025 367.4 million - 65.8 million

AUTL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 266.2 million
March 31, 2026 266.1 million
Dec. 31, 2025 266.1 million
Sept. 30, 2025 266.1 million

AUTL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 913000 27.9 million 41.2 million -
March 31, 2026 2.7 million 21.2 million 40.0 million -
Dec. 31, 2025 23.8 million 35.6 million 35.7 million -
Sept. 30, 2025 15.5 million 27.9 million 36.3 million -

AUTL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 45.7 million 20.5 million
March 31, 2026 26.2 million 24.6 million
Dec. 31, 2025 24.3 million 25.3 million
Sept. 30, 2025 21.2 million 28.6 million

AUTL Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AUTL

Price: $2.15

52 week price:
1.18
2.52

Earnings Per Share: -1.11 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United Kingdom

Volume: 412700

Market Capitalization: 590.8 million

Links: